Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Advanced Bladder Cancer × 90 days × Clear all

Phase

Status

Recruiting 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 143 Neoplasms 124 Carcinoma, Non-Small-Cell Lung 92 Prostatic Neoplasms 72 Colorectal Neoplasms 70 Lung Neoplasms 67 Multiple Myeloma 46 Leukemia, Myeloid, Acute 42 Neoplasm Metastasis 38 Carcinoma, Hepatocellular 35 Recurrence 34 Squamous Cell Carcinoma of Head and Neck 33 Ovarian Neoplasms 30 Brain Neoplasms 29 Stomach Neoplasms 28 Precursor Cell Lymphoblastic Leukemia-Lymphoma 28 Glioblastoma 27 Pancreatic Neoplasms 26 Glioma 26 Uterine Cervical Neoplasms 25 Rectal Neoplasms 24 Endometrial Neoplasms 24 Triple Negative Breast Neoplasms 22 Small Cell Lung Carcinoma 21 Melanoma 20 Colonic Neoplasms 20 Anxiety Disorders 20 Head and Neck Neoplasms 18 Carcinoma, Renal Cell 18 Motor Activity 17

Interventions

pembrolizumab 1 enfortumab vedotin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07346053 2026-01-16

Chrono-EVP

British Columbia Cancer Agency

Phase 3 Not yet recruiting

Advanced Bladder Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡